Search Results - "Raccah, Denis"

Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients by Armougom, Fabrice, Henry, Mireille, Vialettes, Bernard, Raccah, Denis, Raoult, Didier

“…Studies of the bacterial communities of the gut microbiota have revealed a shift in the ratio of Firmicutes and Bacteroidetes in obese patients. Determining…”
Get full text

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate by Lorenz, Martin, Lawson, Francesca, Owens, David, Raccah, Denis, Roy-Duval, Christine, Lehmann, Anne, Perfetti, Riccardo, Blonde, Lawrence

“…While glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are known to increase heart rate (HR), it is insufficiently recognized that the extent varies…”
Get full text

Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study by Préau, Yannis, Galie, Sébastien, Schaepelynck, Pauline, Armand, Martine, Raccah, Denis

“…The switch from intermittently scanned continuous glucose monitoring (isCGM) to real-time (rt) CGM could improve glycemic management in suboptimal controlled…”
Get full text

Health and Pleasure in Consumers' Dietary Food Choices: Individual Differences in the Brain's Value System by Petit, Olivia, Merunka, Dwight, Anton, Jean-Luc, Nazarian, Bruno, Spence, Charles, Cheok, Adrian David, Raccah, Denis, Oullier, Olivier

“…Taking into account how people value the healthiness and tastiness of food at both the behavioral and brain levels may help to better understand and address…”
Get full text

Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial by Benhamou, Pierre-Yves, Franc, Sylvia, Reznik, Yves, Thivolet, Charles, Schaepelynck, Pauline, Renard, Eric, Guerci, Bruno, Chaillous, Lucy, Lukas-Croisier, Celine, Jeandidier, Nathalie, Hanaire, Helene, Borot, Sophie, Doron, Maeva, Jallon, Pierre, Xhaard, Ilham, Melki, Vincent, Meyer, Laurent, Delemer, Brigitte, Guillouche, Marie, Schoumacker-Ley, Laurene, Farret, Anne, Raccah, Denis, Lablanche, Sandrine, Joubert, Michael, Penfornis, Alfred, Charpentier, Guillaume

“…Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop…”
Get full text

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin by Rosenstock, Julio, Raccah, Denis, Korányi, László, Maffei, Laura, Boka, Gabor, Miossec, Patrick, Gerich, John E.

“…OBJECTIVE To compare efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled with metformin…”
Get full text

Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis by Raccah, Denis, Guerci, Bruno, Ajmera, Mayank, Davis, Keith, Meyers, Juliana, Lew, Elisheva, Shaunik, Alka, Blonde, Lawrence

“…Summary Aims To assess the effect of duration of hyperglycaemia before basal insulin (BI) initiation on clinical outcomes in type 2 diabetes (T2D). Materials…”
Get full text

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy by Fonseca, Vivian A., Alvarado-Ruiz, Ricardo, Raccah, Denis, Boka, Gabor, Miossec, Patrick, Gerich, John E.

“…OBJECTIVE To assess efficacy and safety of lixisenatide monotherapy in type 2 diabetes. RESEARCH DESIGN AND METHODS Randomized, double-blind, 12-week study of…”
Get full text

Safety and tolerability of glucagon-like peptide-1 receptor agonists: unresolved and emerging issues by Raccah, Denis

“…Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a mainstay of treatment options for type 2 diabetes. They contribute to lowering blood glucose…”
Get more information

Neuroprotective Effect of Docosahexaenoic Acid-Enriched Phospholipids in Experimental Diabetic Neuropathy by COSTE, Thierry C, GERBI, Alain, VAGUE, Philippe, PIERONI, Gérard, RACCAH, Denis

“…Neuroprotective Effect of Docosahexaenoic Acid-Enriched Phospholipids in Experimental Diabetic Neuropathy Thierry C. Coste 1 , Alain Gerbi 2 , Philippe Vague 1…”
Get full text

Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes by Raccah, Denis, Sulmont, Véronique, Reznik, Yves, Guerci, Bruno, Renard, Eric, Hanaire, Hélène, Jeandidier, Nathalie, Nicolino, Marc

“…Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes The RealTrend study * Denis…”
Get full text

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono) by Fonseca, Vivian A, Alvarado-Ruiz, Ricardo, Raccah, Denis, Boka, Gabor, Miossec, Patrick, Gerich, John E

“…OBJECTIVE: To assess efficacy and safety of lixisenatide monotherapy in type 2 diabetes. RESEARCH DESIGN AND METHODS: Randomized, double-blind, 12-week study…”
Get full text

Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study by Raccah, Denis, Sulmont, Véronique, Reznik, Yves, Guerci, Bruno, Renard, Eric, Hanaire, Hélène, Jeandidier, Nathalie, Nicolino, Marc

“…OBJECTIVE: To compare the improvements in glycemic control associated with transitioning to insulin pump therapy in patients using continuous glucose…”
Get full text

TT Virus Infection in French Hemodialysis Patients: Study of Prevalence and Risk Factors by GALLIAN, P, BERLAND, Y, TOUINSSI, M, CANTALOUBE, J.-F, DUSSOL, B, DE LAMBALLERIE, X, OLMER, M, RACCAH, D, DE MICCO, P, BIAGINI, P, SIMON, S, BOUCHOUAREB, D, MOUREY, C, ROUBICEK, C

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices by Préau, Yannis, Armand, Martine, Galie, Sébastien, Schaepelynck, Pauline, Raccah, Denis

“…Assess the impact of switching from intermittently scanned (FreeStyle Libre [FSL]) to real-time (Dexcom G4 platinum [DG4]) continuous glucose monitoring…”
Get more information

Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitus by Hanefeld, Markolf, Raccah, Denis, Monnier, Louis

“…Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease associated with hyperglycemia, which can lead to serious vascular complications. Current…”
Get more information

Efficacy and safety of lixisenatide in elderly ( ≥65 years old) and very elderly ( ≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme by Raccah, Denis, Miossec, Patrick, Esposito, Virginie, Niemoeller, Elisabeth, Cho, Meehyung, Gerich, John

“…Background The objective of this article is to evaluate the pharmacokinetics, efficacy and safety of lixisenatide (subcutaneous injection) in elderly…”
Get full text

Real‐time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta‐analysis by Benkhadra, Khalid, Alahdab, Fares, Tamhane, Shrikant, Wang, Zhen, Prokop, Larry J., Hirsch, Irl B., Raccah, Denis, Riveline, Jean‐Pierre, Kordonouri, Olga, Murad, Mohammad Hassan

“…Background Real‐time continuous glucose monitoring (RTCGM) may help in the management of individuals with type 1 diabetes mellitus (T1DM); however, the…”
Get full text

A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin by Raccah, Denis, Chou, Engels, Colagiuri, Stephen, Gaàl, Zsolt, Lavalle, Fernando, Mkrtumyan, Ashot, Nikonova, Elena, Tentolouris, Nikolaos, Vidal, Josep, Davies, Melanie

“…Background This study used data from different sources to identify the extent of the unmet need for postprandial glycemic control in patients with type 2…”
Get full text

Impact of Type 2 Diabetes (T2D) Duration on Response to iGlarLixi vs. IGlar—A Subanalysis of LixiLan-L by BLONDE, LAWRENCE, BERARD, LORI, SAREMI, ARAMESH, HUANG, YAO, ARODA, VANITA, RACCAH, DENIS

“…Shorter-acting GLP-1RA like lixisenatide have insulin-independent effects, which may benefit patients (pts) with longer T2D duration and more β-cell…”
Get full text